In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1896 News Items found
Proximal tubule of the kidney.
In the Lab
Miniature Device Could Unlock the Promise of Some Kidney Cancer Drugs

Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs.
MSK investigators Joan Massagué and Anna Obenauf
In the Lab
Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.
CAR T cell therapy
In the Clinic
CAR T Cell Therapies Are a Growing Area of Research

Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.
Pictured: Charles Sawyers
In the Clinic
The Evolution of a Lifesaving Drug: A Scientist Reflects

Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.
Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
In the Lab
Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain?

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.
Epigenetics
Q&A
Setting Cancer Cells on the Right Path: A New Leukemia Drug Shows Growing Promise

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.
New treatments developed at MSK focus on both common and rare cancers.
In the Clinic
Report Highlights Advances Made at MSK That Are Changing Patients’ Lives

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.
Neurons created from embryonic stem cells
In the Lab
Seeing the Light: How Engineered Nerve Cells Might Curb Parkinson’s Disease

A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.
Pictured: Viviane Tabar
In the Lab
Investigators Use Stem Cells to Study Rare Pediatric Brain Tumors

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.
MSK investigators Michael Berger and David Solit.
Finding
Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.